Five key considerations for the administration of your radiopharmaceutical therapy Industry Insights Five key considerations for the administration of your radiopharmaceutical therapy
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves News Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
Key differences between 21 CFR 211 and 21 CFR 212 for radiopharmaceuticals Industry Insights Key differences between 21 CFR 211 and 21 CFR 212 for radiopharmaceuticals
CMS’s CY2025 radiopharma ruling: What you need to know Industry Insights CMS’s CY2025 radiopharma ruling: What you need to know
Progress and predictions for radiopharmaceuticals in 2025 Industry Insights Progress and predictions for radiopharmaceuticals in 2025
2024 recap: New possibilities in radiopharmaceuticals from clinical trials to early-stage treatment Industry Insights 2024 recap: New possibilities in radiopharmaceuticals from clinical trials to early-stage treatment
AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity News AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity
Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints News Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints
Behind the scenes: A day in the life of a radiopharmaceutical production manager Industry Insights Behind the scenes: A day in the life of a radiopharmaceutical production manager
Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy News Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy
